(Q45076328)

9 December 2017

Rituximab treatment of the anti-synthetase syndrome: a retrospective case series (English)

1 reference

9 December 2017

1 reference

2

Oyvind Molberg

1 reference

9 December 2017

3

May Brit Lund

1 reference

9 December 2017

Marthe Sem

1

1 reference

PubMed ID

19531628

9 December 2017

Jan Tore Gran

series ordinal

4

1 reference

9 December 2017

16 June 2009

1 reference

9 December 2017

1 reference

9 December 2017

48

1 reference

9 December 2017

968-971

1 reference

9 December 2017

8

1 reference

9 December 2017

Antisynthetase syndrome

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

The potential utility of B cell-directed biologic therapy in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

B cell-directed therapies for autoimmune disease and correlates of disease response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Rituximab in the treatment of antisynthetase syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP157

10.1093/RHEUMATOLOGY/KEP157

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

19531628